FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds of formula
, where X1, X2, Y, R1a, R1b, R2a, R2b, A1, A2, A3 and A4 have the values specified in the description, which are vanilloid receptor subtype 1 (VR1) antagonists.
EFFECT: preparing a pharmaceutical composition on the basis of the compounds of formula 1 and developing methods of managing pain, neurotic pain, allodynia, inflammation or inflammatory disease associated pain, inflammatory hyperalgesia, bladder hyperactivity and urine incontinence.
22 cl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
BICYCLIC DERIVATIVES | 2019 |
|
RU2794894C2 |
NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
LOCALLY ADMINISTERED COMPOSITION FOR CONTROL OF ANIMAL PARASITES AND THEIR PREVENTION | 2018 |
|
RU2786638C2 |
BICYCLIC DERIVATIVES | 2019 |
|
RU2794895C2 |
SUBSTITUTED BENZAMIDES FOR ARTHROPODA CONTROL | 2014 |
|
RU2713949C2 |
DERIVATIVES OF 2-AMINOPYRIDINE OR 2-AMINOPYRIMIDINE AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2019 |
|
RU2762557C1 |
2-AMINOPYRIDINE OR 2-AMINOPYRIMIDINE DERIVATIVES AS CYCLIN-DEPENDENT KINASE INHIBITORS | 2019 |
|
RU2790006C2 |
ENZYMES INHIBITION | 2013 |
|
RU2638537C2 |
CATALYST SYSTEM | 2005 |
|
RU2372989C2 |
PYRIDYL-SUBSTITUTED HETEROCYCLES, SUITABLE FOR TREATMENT OR PREVENTION OF INFECTIONS, CAUSED BY HEPATITIS C VIRUS | 2003 |
|
RU2331639C2 |
Authors
Dates
2012-05-10—Published
2007-04-12—Filed